Literature DB >> 8163989

Beta amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease.

G W Roberts1, S M Gentleman, A Lynch, L Murray, M Landon, D I Graham.   

Abstract

In a recent preliminary study it was reported that a severe head injury resulted in the deposition of beta amyloid protein (beta AP) in the cortical ribbon of 30% of patients who survived for less than two weeks. Multiple cortical areas have now been examined from 152 patients (age range 8 weeks-81 years) after a severe head injury with a survival time of between four hours and 2.5 years. This series was compared with a group of 44 neurologically normal controls (age range 51 to 80 years). Immunostaining with an antibody to beta AP confirmed the original findings that 30% of cases of head injury have beta AP deposits in one or more cortical areas. Increasing age seemed to accentuate the extent of beta AP deposition and potential correlations with other pathological changes associated with head injury were also investigated. In addition, beta amyloid precursor protein (beta APP) immunoreactivity was increased in the perikarya of neurons in the vicinity of beta AP deposits. The data from this study support proposals that increased expression of beta APP is part of an acute phase response to neuronal injury in the human brain, that extensive overexpression of beta APP can lead to deposition of beta AP and the initiation of an Alzheimer disease-type process within days, and that head injury may be an important aetiological factor in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8163989      PMCID: PMC1072869          DOI: 10.1136/jnnp.57.4.419

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  37 in total

1.  Framing beta-amyloid.

Authors:  J Hardy
Journal:  Nat Genet       Date:  1992-07       Impact factor: 38.330

Review 2.  Alzheimer's disease: pathology to potential treatments?

Authors:  M C Royston; N J Rothwell; G W Roberts
Journal:  Trends Pharmacol Sci       Date:  1992-04       Impact factor: 14.819

3.  On the origin of Alzheimer's disease: a hypothesis.

Authors:  G W Roberts; M Nash; P G Ince; M C Royston; S M Gentleman
Journal:  Neuroreport       Date:  1993-01       Impact factor: 1.837

Review 4.  The role of interleukin-1 in disease.

Authors:  C A Dinarello; S M Wolff
Journal:  N Engl J Med       Date:  1993-01-14       Impact factor: 91.245

Review 5.  Molecular pathology of head trauma: altered beta APP metabolism and the aetiology of Alzheimer's disease.

Authors:  S M Gentleman; D I Graham; G W Roberts
Journal:  Prog Brain Res       Date:  1993       Impact factor: 2.453

6.  Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids.

Authors:  P Seubert; C Vigo-Pelfrey; F Esch; M Lee; H Dovey; D Davis; S Sinha; M Schlossmacher; J Whaley; C Swindlehurst
Journal:  Nature       Date:  1992-09-24       Impact factor: 49.962

7.  Amyloid beta-protein precursor deposition in rat hippocampus lesioned by ibotenic acid injection.

Authors:  Y Nakamura; M Takeda; H Niigawa; S Hariguchi; T Nishimura
Journal:  Neurosci Lett       Date:  1992-02-17       Impact factor: 3.046

8.  Production of the Alzheimer amyloid beta protein by normal proteolytic processing.

Authors:  M Shoji; T E Golde; J Ghiso; T T Cheung; S Estus; L M Shaffer; X D Cai; D M McKay; R Tintner; B Frangione
Journal:  Science       Date:  1992-10-02       Impact factor: 47.728

9.  Amyloid precursor protein mRNA encoding the Kunitz protease inhibitor domain is increased by kainic acid-induced seizures in rat hippocampus.

Authors:  D A Willoughby; S A Johnson; G M Pasinetti; G Tocco; I Najm; M Baudry; C E Finch
Journal:  Exp Neurol       Date:  1992-12       Impact factor: 5.330

View more
  157 in total

1.  Repetitive mild brain trauma accelerates Abeta deposition, lipid peroxidation, and cognitive impairment in a transgenic mouse model of Alzheimer amyloidosis.

Authors:  Kunihiro Uryu; Helmut Laurer; Tracy McIntosh; Domenico Praticò; Daniel Martinez; Susan Leight; Virginia M-Y Lee; John Q Trojanowski
Journal:  J Neurosci       Date:  2002-01-15       Impact factor: 6.167

Review 2.  Traumatic brain injury as a risk factor for Alzheimer's disease: a review.

Authors:  T C Lye; E A Shores
Journal:  Neuropsychol Rev       Date:  2000-06       Impact factor: 7.444

Review 3.  Histone deacetylase inhibitors as therapeutic agents for acute central nervous system injuries.

Authors:  Na'ama A Shein; Esther Shohami
Journal:  Mol Med       Date:  2011-01-25       Impact factor: 6.354

Review 4.  Some evolutionary perspectives on Alzheimer's disease pathogenesis and pathology.

Authors:  Daniel J Glass; Steven E Arnold
Journal:  Alzheimers Dement       Date:  2011-12-03       Impact factor: 21.566

5.  Blood-brain barrier pathophysiology in traumatic brain injury.

Authors:  Adam Chodobski; Brian J Zink; Joanna Szmydynger-Chodobska
Journal:  Transl Stroke Res       Date:  2011-12       Impact factor: 6.829

Review 6.  Chronic traumatic encephalopathy: a potential late effect of sport-related concussive and subconcussive head trauma.

Authors:  Brandon E Gavett; Robert A Stern; Ann C McKee
Journal:  Clin Sports Med       Date:  2011-01       Impact factor: 2.182

Review 7.  Dementia resulting from traumatic brain injury: what is the pathology?

Authors:  Sharon Shively; Ann I Scher; Daniel P Perl; Ramon Diaz-Arrastia
Journal:  Arch Neurol       Date:  2012-10

Review 8.  The keystone of Alzheimer pathogenesis might be sought in Aβ physiology.

Authors:  D Puzzo; W Gulisano; O Arancio; A Palmeri
Journal:  Neuroscience       Date:  2015-08-24       Impact factor: 3.590

Review 9.  Axonal pathology in traumatic brain injury.

Authors:  Victoria E Johnson; William Stewart; Douglas H Smith
Journal:  Exp Neurol       Date:  2012-01-20       Impact factor: 5.330

10.  Human apolipoprotein E4 worsens acute axonal pathology but not amyloid-β immunoreactivity after traumatic brain injury in 3xTG-AD mice.

Authors:  Rachel E Bennett; Thomas J Esparza; Hal A Lewis; Eddie Kim; Christine L Mac Donald; Patrick M Sullivan; David L Brody
Journal:  J Neuropathol Exp Neurol       Date:  2013-05       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.